Shares of Nanobiotix (NBTX), a biotechnology company, soared 6.51% in after-hours trading on Wednesday, building on positive sentiment from a bullish analyst report. The stock's movement comes as investors react to Leerink Partners' reaffirmation of its Buy rating on the company.

Leerink Partners analyst Jonathan Chang maintained a Buy rating on Nanobiotix and set an ambitious price target of $24.00. This target suggests significant upside potential from the stock's current trading levels, likely contributing to the after-hours rally.

The sustained positive outlook from a respected Wall Street firm appears to have bolstered investor confidence in Nanobiotix's prospects. While specific details of Chang's analysis were not provided, the maintained Buy rating and high price target imply a strong belief in the company's future performance and potential market opportunities. Investors will be watching closely to see if this after-hours momentum carries into regular trading sessions and whether other analysts follow suit with similarly optimistic views on Nanobiotix.